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1. Introduction 
Since Parodi reported the first successful endovascular aneurysm repair procedure in 1991, 
this procedure has gained wide acceptance for the treatment of abdominal aortic aneurysms 
in the past two decades. This minimally invasive approach has been proven effective and 
safe in the treatment of abdominal aortic aneurysm patients with lower early morbidity and 
mortality rates compared to open surgery repair. Meanwhile, dozens of endografts have 
been designed for endovascular aneurysm repair, and most of them are now still 
undergoing modification and improvement. Although these devices have been improved 
over time, secondary procedures are required in up to 27% of patients following 
endovascular aneurysm repair. Complications of stent-graft migration, endoleaks, stent 
rupture/fracture, aortic neck dilatation and development of other aortoiliac aneurysms 
mandate lifelong patient follow-up. 
Among these complications the most prevalent and concerning complications are distal 
migration (defined by the Society for Vascular Surgery as device movement of greater than 
10 mm or lesser device movement necessitating secondary intervention) and Type I 
endoleak, putting the patients under an increasing risk of aneurysm rupture. Migration has 
a reported incidence of up to 45%, and has been shown in biomechanical analyses to be the 
result of both persistent downward flow upon the stent-graft bifurcation (affecting neck 
fixation), and transverse forces, resulting in device lateral movement (affecting neck fixation, 
component stability, and iliac fixation). Type I endoleak is closely associated with migration, 
and is certainly the most significant predictor of aneurysm increase, risk of rupture, and 
need for secondary intervention or open conversion repair. 
Therefore, the most favorable design of endovascular aneurysm repair endograft should 
theoretically support to counteract the downward force of pulsatile blood flow and possibly 
prevent distal migration. Now on the market most of the endovascular aneurysm repair 
endografts are modular devices and deployed from proximal to distal. The Endologix 
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(Irvine, CA, USA) PowerlinkR device is the only unibody endograft which is deployed at the 
aortic bifurcation (“anatomical fixation”). From our nearly 16 years experience of more than 
1700 (ending in November 2009) endovascular aneurysm repair cases with 13 different 
endografts, we prefer the PowerlinkR unibody bifurcated device for this challenge. Ending 
in December 2008, 612 cases of endovascular aneurysm repair were performed using the 
PowerlinkR device in our single center, in 513 patients the devices were implanted 
“anatomically” from the aortoiliac bifurcation to the renal artery level with or without 
proximal cuff and/or additional PalmazR stent. We have published our outcomes with the 
PowerlinkR for abdominal aortic aneurysms in the last years. In one article, the results 
included the cases that deployed not “anatomically”. The objective of this report is to 
summarize our 12-year experience of endovascular aneurysm repair for abdominal aortic 
aneurysm with the PowerlinkR stent-graft deployed “anatomically”.  
2. Methods 
2.1 Patient sample 
From February 1999 to December 2008, 612 patients with infrarenal abdominal aortic 
aneurysm were evaluated for endovascular aneurysm repair treatment with the Endologix 
PowerlinkR endograft in our center. Of this cohort in 513 patients the devices were 
implanted “anatomically” from the aortoiliac bifurcation to the renal artery level with or 
without proximal cuff and/or additional PalmazR stent. According to the American Society 
of Anesthesiologists’ physical status classification there were 60.8% (312/513) cases in ASA 
III/IV stage. The follow-up imaging was performed at 1 month, 6 months and yearly 
thereafter. Computed tomography angiograms with a 2.5-mm slice thickness were routinely 
performed to determine endovascular aneurysm repair eligibility. Data of these 513 patients 
were retrospectively analyzed in the study. Of these 513 patients, a special analysis was also 
made of data from 117 cases with short and/or angulated necks (from February 1999 to 
December 2007) (Table 1).  
 
 
Short neck  
(11-15 mm) 
Very short neck  
(< 10 mm) 
Angulated neck  
(> 60) 
Number of cases 54 26 37 
Mean age, years 72.2 73.1 72.7 
Male 50 (93%) 23 (88%) 32 (86%) 
Mean AAA 
diameter, cm 
5.8 6.1 6.3 
ASA class III/IV 44 (81%) 21 (81%) 31 (84%) 
Table 1. Demographics and Patients Characteristics 
2.2 Endologix PowerlinkR system 
The PowerlinkR main body device is an unibody bifurcated endograft consisting of a fully 
supported, high density, low porosity expanded polytetrafluoroethylene (ePTFE) graft with 
an endoskeleton constructed as a single-wire, cobalt chromium alloy body with limbs. The 
graft is attached to the stent only at the proximal and distal ends using surgical suture, a 
feature that results in excellent resistance to stent fracture or fatigue. Accessory proximal 
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extensions are constructed in like manner, with both infrarenal configurations and 
suprarenal PowerFit™ configurations available (Figure 1).  
Accessory limb extensions in straight, stepped, flared, and tapered configurations are 
available to permit customization to patient anatomy as needed (Figure 2). Device 
availability permits the treatment of patients with proximal aortic neck diameters of 18 to 32 
mm, and distal iliac seal zone diameters of 10 to 23 mm. The low profile 19 Fr delivery 
system introducer requires only one surgically exposed femoral artery for deployment. 
Unique to this device, contralateral access is obtained percutaneously (9Fr) through a pre-
cannulated contralateral limb. These features enable use of the device in patients with one 
small or severely diseased iliac access vessel, where with available proximal fixation 
devices, this is not possible. The PowerlinkR design and access flexibility thus increase the 
number of patients that can be electively treated by endovascular aneurysm repair. 
Moreover, the use of the integrated introducer sheath for accessory delivery and 
deployment and ancillary device introduction reduces the need for exchanges, thereby 
minimizing the potential for vessel intimal injury (Figure 3). 
 
 
Fig. 1. PowerlinkR Endografts (Unibody bifurcated, PowerFitTM) 
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Fig. 2. PowerlinkR Endografts Accessory limb extensions (straight, tapered, flared and 
stepped extensions) 
 
 
Fig. 3. IntuiTrak endovascular abdominal aortic aneurysm system (Flexible, low profile 
delivery system, anatomical fixation, Pre-cannulated 9F contralateral limb, Hydrophilic 
coated sheath, Simple and controlled deployment) 
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2.3 EVAR procedure with the PowerlinkR system 
Stent-graft selection is based on pre-operative and intra-operative measurements of aortic 
non-aneurysmal neck diameter, aortic length from the most caudal renal artery to the aortic 
bifurcation, and length from the aortic bifurcation to the hypogastric arteries. Procedures are 
performed in suitably equipped operating rooms or endovascular suites with operating 
room availability. Proper fluoroscopic imaging equipment and tools include a mobile C-
arm, automated contrast injector, intraoperative angiography, and if preferred, intravascular 
ultrasound. Bifurcated and, as needed, proximal extension stent-graft models are chosen per 
established sizing algorithms, while achieving proximal seal and fully lining the infrarenal 
aorta. After angiography and aortic length verification with a marker catheter, the 
bifurcated stent graft delivery system contralateral guidewire is placed, and the integrated 
19Fr introducer sheath is advanced over the stiff guidewire into the aorta. Under 
fluoroscopic visualization, the introducer sheath is retracted to expose the constrained 
bifurcated stent graft. The constrained device is then placed upon the aortoiliac bifurcation, 
after which the main body and each limb of the device are deployed using a simple yet 
metered control cord mechanism. This results in implantation of the device at the aortoiliac 
bifurcation (i.e., anatomical fixation). Based on the patient anatomy and intraoperative 
angiography, an accessory proximal extension is placed as needed to achieve adequate 
overlap with the bifurcated device and seal in the proximal neck (Figure 4). Limb extensions 
can similarly be placed as needed to accommodate patient anatomical needs. Balloon 
dilatation may be performed if desired. 
 
 
Fig. 4. Image of the Anatomically Fixed PowerlinkR Implant. Full aortic relining and 
proximal seal are completed with the PowerFitTM proximal extension. 
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2.4 PalmazR stent and deployment procedure 
PalmazR stents are inserted through a 14-F Check-Flo Performer introducer (Cook, 
Bloomington, IN, USA). The stent can be expanded to 14-25 mm correspondingly the length 
from 37.79-30.58 mm. The stent was advanced and deployed across the renal arteries and top 
of the graft with a MAXI LD PTA balloon dilation catheter (Cordis, Miami, FL, USA). We 
usually choose a P4014 PalmazR stent, a 25mm-diameter expandable balloon and a 45cm-long 
14F sheath (Figure 5). The balloon had better be inflated one time whose surface is relatively 
coarse to prevent the stent from dislocation in the course of deployment. The PalmazR stent 
was asymmetrically hand-crimped on an expandable balloon that ensures that the proximal 
(cranial) aspect will expand first. A long sheath is placed distal to the target area. We regularly 
deploy the PalmazR stent with one third above the renal artery, since when we dilate the 
PalmazR stent, it shortens. Once the balloon and stent assembly is in position, the sheath is 
partially retracted to allow only the proximal (cranial) half of the balloon to expand, flaring the 
unsheathed proximal stent. The expanded proximal balloon prevents cranial stent migration. 
The sheath prevents distal (caudal) stent migration. Full retraction of the sheath allows the 
distal balloon and stent to expand, completing the stent deployment (Figure 6). 
 
 
Fig. 5. A P4014 PalmazR stent and a MAXI LD PTA expandable balloon 
 
 
Fig. 6. Details of the deployment procedure of PalmazR stent. (A) The stent loaded off-center 
on the balloon is positioned at the intended area of deployment through the sheath under 
fluoroscopic guidance. (B) The sheath is partially retracted and the balloon is insufflated, 
deploying the proximal (cranial) portion of the stent. (C) Fully deployed stent. 
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2.5 Follow-up 
All patients were evaluated before discharge; at 1 and 6 months; and annually thereafter to 
assess clinical symptoms, potential endoleaks, and aneurysm size. Computed tomography 
angiogram was performed at each visit; digital subtract angiography was used selectively in 
special cases, such as visible endoleak or aneurysm sac enlargement seen on computed 
tomography angiograms.  
3. Results 
This study cohort included 513 consecutive patients (mean age 72.9±8.0 years, male 461); the 
mean maximal aneurysm diameter was 54.6±8.9 mm. 86 (16.8%) cases underwent 
preliminary hypogastric embolisation in the presence of common iliac artery and/or 
hypogastric artery aneurysm or a too short common iliac artery. The technical success rate 
was 98.4% (505/513), emergent open conversion occurred in 8 cases (1.6%) because of 
delivery access problem. The proximal cuff was used in 61.0% (308/505), PalmazR stent in 
20.6% (104/505), limb extension in 14.3% (72/505), retrograde iliac artery endarterectomy 
and femoral patchplasty in 27 (5.3%) cases, iliac-femoral graft interposition in two cases. 
Primary type Ia endoleak occurred in 20 cases (4.0%) and all were remedied intraoperatively 
by PalmazR stent or the endoleaks were considered so minimal that spontaneous vanish 
would be expected in close follow-up. 18 (3.5%) cases had type II endoleak and were under 
routine observation. Mean procedure time was 55±21 min. The 30-day mortality rate was 
0.4% (2/513) (Table 2). 
 
 Whole group 
Short and/or angulated neck 
group 
Case number 513 117 
Range time 2/1999-12/2008 2/1999-12/2007 
Technical success rate 98.4% (505/513) 97.4% (114/117) 
Emergent conversion rate 1.6% (8/513) 2.6% (3/117) 
Proximal cuff 61.0% (308/505) 100% (114/114) 
PalmazR stent 20.6% (104/505) 72.8% (83/114) 
Primary type Ia endoleak 4.0% (20/505) 5.3% (6/114) 
Type II endoleak 3.5% (18/505) 4.4% (5/114) 
30-day mortality rate 0.4% (2/513) 1.7% (2/117) 
Table 2. Procedure details and perioperative complications 
503 cases were followed up for mean 5.2 years (range, 2 months–9.5 years). Proximal type I 
endoleak existed in 6 cases (1.2%), all of them were primary type Ia endoleaks, 4 were 
revised with proximal cuff and/or PalmazR stent and 2 by selective open conversion. Type II 
endoleak existed in 22 cases (4.4%), limb occlusion rate was 1.0% (5/503), partial renal 
infarction occurred in 9 cases (1.8%) and selective open conversion rate was 1.6% (8/503). 
There were no aneurysms rupture, no device migration, no type III/IV endoleak and stent-
graft rupture/fracture. A reduction in mean aneurysm sac diameters and volumes has been 
noted at every follow-up interval (Table 3).  
Of the 117 patients with short and/or angulated neck, the technical success rate was 97.4% 
(114/117). Intraoperative complications included 3 (2.6%) emergent open conversions due to 
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delivery access problem, 6 (5.3%) primary type Ia endoleaks and 5 (4.4%) type II endoleaks. 
The 30-day mortality was 1.7% (2/117) (Table 2, 4).  
The 2.6-year follow-up results showed 4 (3.6%) primary type Ia endoleaks, which were 
revised with proximal cuff and/or PalmazR stent. Limb occlusion occurred in 2 (1.8%) cases. 
There were no open conversion, no aneurysm rupture, no device migration, no type III/IV 
endoleaks and stent-graft rupture/fracture (Table 3, 5). 
 
 Whole group 
Short and/or angulated neck 
group 
Case number 513 117 
Follow-up case number 503 112 
Follow-up mean period 5.2 years 2.6 years 
Type Ia endoleak 1.2% (6/503) 3.6% (4/112) 
Type II endoleak 4.4% (22/503) 2.7% (3/112) 
Limb occlusion rate 1.0% (5/503) 1.8% (2/112) 
Partial renal infarction 1.8% (9/503) 2.7% (3/112) 
Selective conversion rate 1.6% (8/503) 0.0% (0/112) 
Aneurysm rupture 0 0 
Device migration 0 0 
Type III/IV endoleak 0 0 
Stent-graft rupture 0 0 
Table 3. Intraoperative and postoperative results 
 
 Short neck (n=54) 
Very short neck 
(n=26) 
Angulated neck 
(n=37) 
Successful implantation 52 (96.3%) 26 (100%) 37 (97.3%) 
Delivery access 
problem 
2 0 1 
One proximal cuff 50 (96.2%) 22 (84.6%) 29 (80.6%) 
Two proximal cuffs 2 (3.8%) 4 (15.4%) 7 (19.4%) 
Proximal Palmaz stent 42 (80.8%) 23 (88.5%) 18 (50.0%) 
Limb extension 6 (11.5%) 3 (11.5%) 3 (8.3%) 
Suprarenal fixation 48 (92.3%) 26 (100%) 33 (91.7%) 
Infrarenal fixation 4 (7.7%) 0 3 (9.3%) 
Retrograde iliac TEA 3 (5.8%) 1 (3.8%) 2 (5.6%) 
Femoral 
patch/angioplasty 
3 (5.8%) 2 (7.6%) 3 (8.3%) 
Iliac-fem bypass 0 0 1 
Proximal type I 
endoleak 
3 (5.8%) 1 (3.8%) 2 (5.6%) 
Type II 2 (3.8%) 1 (3.8%) 2 (5.6%) 
Type III/IV 0 0 0 
Table 4. Procedure details and intraoperative complications in the hostile neck anatomy 
group 
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 Short neck (n=54) 
Very short neck 
(n=26) 
Angulated neck 
(n=37) 
Proximal type I 
endoleak 
2 (3.8%) 1 (3.8%) 1 (2.8%) 
Type II endoleak 2 (3.8%) 0 1 (2.8%) 
Partial renal 
infarction 
2 (3.8%) 0 1 (2.8%) 
Distal migration 0 0 0 
Stent kinking 0 0 0 
Limb occlusion 1 (1.9%) 0 1 (2.8%) 
Table 5. Mean 2.6 years follow-up results in hostile neck anatomy group 
4. Discussions 
The applicability of endovascular aneurysm repair in abdominal aortic aneurysms mainly 
depends on the aortoiliac anatomy and morphology. Among all the challenging factors 
limiting application of this minimally invasive technique, the infrarenal aortic aneurysm neck 
morphology is still the most important determinant. The infrarenal neck length and angulation 
are the first parameters we should consider in the indication for endovascular aneurysm 
repair. Some clinical studies have made it clear that abdominal aortic aneurysms with short 
and/or angulated necks for endovascular aneurysm repair have a high risk of stent-graft distal 
migration and proximal type I endoleak, which make up the exact criteria in challenging cases. 
In one EUROSTAR study, 5183 patients underwent endovascular aneurysm repair from 
October 1996 to January 2006. Incidence of stent-graft migration, proximal type I endoleak, 
proximal neck dilatation, secondary interventions, aneurysm rupture, and all-cause and 
aneurysm-related mortality were compared between patients with and without severe 
infrarenal neck angulation (> 60 degrees angle between the infrarenal aortic neck and the 
longitudinal axis of the aneurysm). In the short term (before discharge), stent-graft migration 
(OR 2.17, 95% CI 1.20 to 3.91, p=0.0105) and proximal type I endoleak (OR 2.32, 95% CI 1.60 to 
3.37, p<0.0001) were observed more frequently in patients with severe infrarenal neck 
angulation. Over the long term, proximal type I endoleak (HR 1.80, 95% CI 1.25 to 2.58, 
p=0.0016), higher incidences of proximal neck dilatation (> or =4 mm) (HR 1.26, 95% CI 1.11 to 
1.43, p=0.0004) and need for secondary interventions (HR 1.29, 95% CI 1.00 to 1.67, p=0.0488) 
were seen in the severe infrarenal neck angulation group. All-cause mortality, rupture of the 
aneurysm and aneurysm-related mortality were similar in patients with and without severe 
infrarenal neck angulation. In the subgroup of patients with an Excluder endograft, proximal 
endoleak at the completion angiogram (OR 4.49, 95% CI 1.31 to 15.32, p=0.0166) and long-term 
proximal neck dilatation (HR 1.67, 95% CI 1.20 to 2.33, p=0.0026) were more frequently 
observed in patients with severe infrarenal neck angulation. 
The endovascular aneurysm repair mechanism is to construct an endoluminal exclusion 
channel inside the native aortoiliac artery to exclude the aneurysm from the dynamic blood 
flow to prevent rupture, and the endoluminal exclusion channel must be stable and sealed. 
But short necks are unable to provide sufficient proximal landing zone for secure fixation 
and seal; angulated necks are unable to provide proper anchoring adaptation for secure 
fixation and seal. Is there an optimal device to adapt to these challenging anatomies? Most 
of the authors and the currently available devices emphasize the proximal fixation with 
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bars/hooks/crimps and suprarenal fixation, but device distal migration is still unavoidable. 
Interestingly, all the currently available modular devices were designed to implant starting 
just below the renal arteries, which will result in hanging the device inside the aneurysm 
sac. From the dynamic mechanism, it is not stable, as the blood flow through the stent-graft 
acts as a displacing force, and the endograft is normally held in position by friction 
dependant on the radial force of the graft against the aortic wall and the contact surface 
between the graft material and the artery wall.  
Completely contrary to these modular devices, the PowerlinkR one-piece long main body 
bifurcated stent-graft was designed to be implanted sitting on the native abdominal aortic 
bifurcation. We have termed this technique “Anatomical Fixation”, which proved effective in 
eradicating distal migration. Mimicking construction of a building, the endoluminal exclusion 
channel can be built up to the renal artery level with an oversized long suprarenal proximal 
cuff. After endograft stability has been achieved, more attention should be paid to the 
proximal fixation and seal. A compulsory ballooning of the neck and the conjunction part was 
routinely carried out for better adaptation. PalmazR stent implantation depends on the 
angiogram outcome. We normally implant the PalmazR stent only if there is a high risk of 
proximal type I endoleak. A PalmazR stent is used in the neck to strengthen the radial fixation 
force and to adapt the graft to the aortic wall for better seal. Balloon-expandable PalmazR stent 
has been proven to provide better seal as well as fixation in treating hostile necks.  
Qu et al reported their results of 612 eligible abdominal aortic aneurysm patients underwent 
endovascular aneurysm repair between 1999 and 2008 using the PowerlinkR System in our 
center. Of the 612 patients, 99 cases (16%) completed between 1999 and 2004 had the endograft 
deployed from the renal artery downward. The remaining 513 cases (84%) completed 
afterwards had the bifurcated stent-graft deployed onto the native aortoiliac bifurcation. 
Among the 513 cases, 146 cases (28%) were deemed as challenging anatomy with short and/or 
angulated neck. Technical success was achieved in 98.5% of patients (603/612). Intraoperative 
emergent open conversion occurred in 9 patients, 8 of which were due to delivery access 
problems and 1 due to rupture. 3 deaths and 2 limb occlusions were encountered 
perioperatively. During the follow-up (mean: 5.2 years; maximum: 9.5 years), 1 rupture and 7 
migrations occurred, all of which were in patients in whom the device was fixed at the level of 
the renal arteries. The rates of late selective open conversion in the renal fixation and 
anatomical fixation groups were 4.0% and 1.9%, respectively. Likewise, the cumulative rates of 
proximal type I endoleak in the groups of renal fixation and anatomical fixation were 5.0% and 
1.2%, respectively. Remarkably, no stent fracture, graft disruption and type III/type IV 
endoleaks were observed in any patient. Harlin et al also reported the new results of 44 
consecutive eligible patients enrolled in eight US sites between 2006 and 2008. Each patient 
underwent a PowerlinkR infrarenal bifurcated stent-graft with anatomical fixation onto the 
native aortoiliac bifurcation and a suprarenal proximal cuff to achieve proximal sealing. 
Challenging infrarenal aortic neck anatomy was present in 93% of patients. Technical success 
rate was 100%. No aneurysm-related deaths, open conversions, migrations, or type III/IV 
endoleaks were observed. The majority of endoleaks (80%) observed during follow up were 
type II. The primary clinical success rate was 93%. Two secondary endovascular procedures 
were performed for type Ia or type Ib endoleak, and one surgical intervention was performed 
for resolution of limb occlusion. Significant reduction in sac diameter has been observed to up 
to 2 years. Between September 2005 and June 2008, a prospective, multicenter, pivotal US Food 
and Drug Administration trial of the Powerlink XL System for endovascular aneurysm repair 
was conducted at 13 centers. A total of 78 patients presenting with abdominal aortic aneurysm 
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and an infrarenal aortic neck up to 32 mm in diameter received the bifurcated stent-graft with 
anatomical fixation onto the native aortoiliac bifurcation and proximal sealing with a 
Powerlink XL infrarenal proximal extension stent-graft. Challenging infrarenal aortic neck 
anatomy was present in 85% of patients. Technical success was achieved in 98.7% of patients, 
with one patient requiring femoral-femoral bypass intraoperatively. Aneurysm exclusion was 
achieved in 100% of patients. At the one-month CT scan, the independent core lab identified a 
Type II endoleak in 13 patients, Type Ib and Type II endoleaks in one patient, and unknown 
endoleak in three patients. At 30 days, there were no deaths, open conversions, ruptures, or 
migrations. Through one year follow-up, Type II endoleak predominated (9/10 patients with 
endoleak), with one proximal Type I endoleak and no Type III/IV; no conversions, ruptures, 
or migrations have been observed. The one-year all-cause mortality rate was 6.4%, with 100% 
freedom from aneurysm-related mortality. Secondary procedures were performed within one 
year in five patients (6.4%) for treatment of proximal Type I endoleak (n = 2), proximal Type 
I/Type II endoleak (n = 1), and distal Type I endoleak (n = 2). Reduced or stable aneurysm sac 
diameter at one year was observed in 96% of patients. All these results suggest that anatomical 
fixation at the native aortic bifurcation can provide secure fixation for cases with hostile 
proximal aortic necks. 
Short-term results suggested the use of the prophylactic adjunctive balloon-expandable 
PalmazR stents may decrease the incidence of secondary interventions related to challenging 
neck anatomy when used as an adjunctive measure with endovascular aneurysm repair. 
Cox et al reviewed their experience of endovascular aneurysm repair with use of the 
PalmazR stents in patients with hostile neck anatomy and type I endoleaks. Of 140 patients 
who underwent endovascular aneurysm repair between 2000 and 2004, they reviewed data 
of 19 patients in whom they used the proximal balloon-expandable stents. PalmazR stents 
were deployed in the proximal graft with transrenal extension. AneuRx (18/19) and Zenith 
(1/19) endografts were used in all of the patients. Of the 19 patients, 15 had the prophylactic 
stent placement for known hostile neck anatomy and 4 patients had stent placement for type 
I endoleak. Assisted primary technical success was achieved in all patients. Three patients 
had maldeployment of the endograft or proximal stent requiring additional endovascular 
interventions at the time of surgery. No endografts were deployed too low requiring stent 
placement. Procedure-related complications occurred in 2 of 19 patients. These included 1 
operative death secondary to pneumonia and 1 patient who developed progressive renal 
failure. Short-term clinical success was achieved in 17 of 19 patients. Two patients required 
secondary interventions, 1 due to device migration with secondary conversion to open 
repair, and an endoleak, which, on angiogram, was a large type II endoleak successfully 
treated with coiling of the inferior mesenteric artery. One patient was observed to have a 
type II endoleak with no associated aneurysm enlargement. Another retrospective review 
was made of 250 consecutive abdominal aortic aneurysm cases with hostile necks that 
underwent commercially available endograft treatment adjunctive with the PalmazR stent in 
Arizona heart institute and Nuremberg south hospital from September 2005 to November 
2009. The primary technical success rate was 83.6% (209/250). The mean time of follow-up 
was 23.4 months; the overall clinical success rate was 95.2% (238/250). The overall 
conversion rate was 2.4% (6/250) due to large proximal type I endoleak and sac 
enlargement. There was no neck dilation or graft migration. These results showed 
deployment of the PalmazR stent in hostile necks has proved to be easy, effective and safe. 
At the beginning, most of the abdominal aortic aneurysm cases in our center were performed 
according to the publicly accepted anatomical criteria for endovascular aneurysm repair. With 
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accumulation of experience, the indication of endovascular aneurysm repair has been widely 
broadened. Abiding by the above philosophy, approximately 90%-95% of infrarenal 
abdominal aortic aneurysms in our unit can be treated with endovascular aneurysm repair, 
and we are treating more and more challenging cases (such as short neck, angulated neck, 
thrombus-affiliated neck, calcified neck and surface-irregular neck, et al) in this way.  
In the whole group, with a mean 5.2-year long-term follow-up, the type Ia endoleak rate was 
only 1.2% (6/503). Even in the short and/or angulated neck group with mean 2.6-year mid-
term follow-up, the proximal type I endoleak rate was 3.6% (4/112), without open 
conversion and distal migration. Our results have strongly demonstrated that the Endologix 
PowerlinkR endograft with “anatomical fixation” is very effective to prevent migration and 
type Ia endoleak for abdominal aortic aneurysms with challenging neck anatomy.  
After building upon the foundation of the bifurcated endograft, a suprarenal proximal cuff 
with a long overlapping segment inside the bifurcated main body endograft is built up to the 
renal artery level. In our whole group, proximal long cuff was used in 61.0% (308/505) cases, 
and in the hostile neck group, all the patients had the proximal long cuff. This long cuff is not 
only used for prevention of type III endoleak but also useful for stretching the angulated 
segment of the infrarenal aorta, namely remodeling and straightening the proximal angulated 
neck. 20.6% (104/505) and 72.8% (83/114) patients had proximal PalmazR stents in the whole 
group and the hostile neck group, respectively, resulting in further remodeling of the 
infrarenal aorta with more contact area for better fixation and seal (Figure 7). 
 
 
Fig. 7. Angiography-pictures after deployment of the PowerlinkR bifurcated main body 
stent, the first PowerFitTM proximal cuff, the second PowerFitTM proximal cuff, the PalmazR 
stent in turn 
Regarding the device size choice, the PowerlinkR unibody bifurcated stent-graft is different 
from the modular devices. The distance from the lowest renal artery to the abdominal aortic 
bifurcation, and the distance from the aortic bifurcation to the hypogastric artery are 
important parameters for the size choice. Graft length is determined by the lengths of the 
native abdominal aorta and the common iliac artery. Graft diameter is determined by 
oversizing the endograft by 10-20% in excess of the measured neck diameter. Due to the 
several standard sizes of the main body, proximal cuff and limb extension, this system 
proved simple and easy for size selection. The most commonly used main body size in our 
unit is 25 mm in neck diameter, 10 cm in main body length, 16 mm in limb diameter, and 5.5 
cm in limb length. The most commonly used suprarenal proximal cuff is 28 mm in diameter 
and 75 mm or 95 mm in length. 
Common iliac aneurysm and/or hypogastric artery aneurysm or a too short common iliac 
artery can prevent safe and successful anchoring of the distal end of the limb of the stent. Some 
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studies reported that common iliac artery aneurysms exist in about 20% to 30% of patients 
with abdominal aortic aneurysms who were examined for endovascular aneurysm repair. In 
our study, the applicability of endovascular aneurysm repair was increased by 16.8% (86/513) 
after preliminary hypogastric aneurysm embolization. Therefore, preliminary embolization of 
hypogastric artery with additional extension of the graft to the external iliac artery may 
expand the indication of endovascular aneurysm repair. But we all know that hypogastric 
artery embolization will cause pelvic ischemic complications such as buttock claudication, 
sexual dysfunction and other pelvic ischemia symptoms (e.g., gluteal necrosis, spinal cord 
ischemia, rectosigmoid ischemia, or limb ischemia). In our center, a retrospective review was 
conducted of all 101 consecutive patients (91 men; mean age 73.4 ± 8.7 years) who underwent 
preliminary embolization of 133 hypogastric arteries about 4 to 6 weeks prior to endovascular 
aneurysm repair from January 2005 to August 2009. Fourteen patients with 19 hypogastric 
arteries were treated using coils, while 87 patients were treated with Amplatzer Vascular Plugs 
in 114 hypogastric arteries. In the coil group, complete occlusion was achieved in 16 (84.2%) of 
19 procedures. There were no acute pelvic ischemic symptoms after hypogastric artery 
embolization or endovascular aneurysm repair. Five (35.7%) patients had buttock claudication 
and 2 (16.7%) of 12 men experienced new erectile dysfunction after embolization. At a mean 
42.2-month follow-up (range 14-58), 3 (21.4%) patients had a type II endoleak via retrograde 
flow in the hypogastric artery without aneurysm growth and were under observation. In the 
Amplatzer Vascular Plugs group, all 114 hypogastric arteries in 87 patients were successfully 
occluded; there was no device dislodgment or limb ischemia observed. Buttock claudication 
and new sexual dysfunction developed in 12 (13.8%) patients and 4 (5.1%) of 79 men after the 
procedure, respectively. During a mean 26.4-month follow-up (range 4-54), 2 (2.3%) patients 
developed distal type I endoleaks after endovascular aneurysm repair, but angiography 
confirmed that neither of the endoleaks was related to the vessel embolized with the 
Amplatzer Vascular Plugs. Comparing the outcomes of the treatment groups, the Amplatzer 
Vascular Plugs was placed with fewer intraoperative complications (p=0.013) and more 
complete occlusion (p=0.01) than coil embolization. The rate of buttock claudication was lower 
in the Amplatzer Vascular Plugs group (p=0.042). Our clinical researches showed that 
hypogastric aneurysm embolization prior to endovascular aneurysm repair is safe and 
effective. The AmplatzerR Vascular Plug affords easier and more precise placement and 
provides more complete occlusion, with fewer intraoperative and postoperative ischemic 
complications than coil embolization.  
For proximal type I endoleak, balloon angioplasty is first recommended in our experience. If 
it does not work, a PalmazR stent in the aneurysm neck is able to cure the endoleak. There 
were 20 cases and 6 cases of primary proximal type I endoleaks in the whole group and the 
short and/or angulated neck group after balloon angioplasty, respectively. But after the 
deployment of the palmazR stent, all of them were remedied or minimal that spontaneous 
vanish was expected by operators in the follow-up. During the mid-term or long-term 
follow-up, only 6 and 4 primary proximal type I endoleak still existed in the two groups. If 
there is still some space between the renal artery and the top of the stent-graft, a suprarenal 
proximal cuff with or without PalmazR stent can achieve a good result. Only 2 cases in the 
whole group underwent selective open conversion, the other 4 were all remedied by 
endovascular re-intervention.  
Delivery access problems were the main reasons for emergent open conversion. In our 
study, all of the intraoperative emergent open conversion occurred because of the delivery 
access problems. But with the accumulation of our experience, for most stenotic iliac 
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arteries, pre-dilatation with an 8 mm or 10 mm angioplasty balloon can usually solve the 
problem. If not, we preferred retrograde iliac artery endarterectomy with Moll Ring cutter. 
9 (1.8%) cases in the whole group suffered from partial renal infarction found on computed 
tomography scan, but the renal function was not impaired. Though all these 9 cases had 
suprarenal fixation, a controlled study from two pivotal US Food and Drug Administration 
trials using the PowerlinkR bifurcated stent-graft revealed that suprarenal fixation does not 
lead to a significant increase in acute renal events, renal impairment, or alteration in blood 
pressure compared with infrarenal fixation. During the trials, 283 patients underwent 
endovascular aneurysm repair with the PowerlinkR bifurcated stent-graft. A comparison of 
preoperative, perioperative (1 ~ 7 days), and postoperative (>7 days) alterations in serum 
creatinine, creatinine clearance and blood pressure was done. Renal adverse events were 
determined by computed tomography scan and clinical chart review and included renal 
infarction, renal artery stenosis (either progressive or requiring renal stent placement) and 
renal artery occlusion. Both suprarenal fixation and infrarenal fixation groups showed a 
significant increase in serum creatinine and a decrease in creatinine clearance over time. No 
significant difference in serum creatinine or creatinine clearance existed between groups 
during any time period. There were no differences in postoperative renal impairment 
(infrarenal, 10.2%; suprarenal, 7.6%, P = 0.634), the need for hemodialysis (infrarenal, 0.7%; 
suprarenal, 0%, P = 1.00), systolic and diastolic blood pressure during subsequent follow-up 
between treatment groups. There was no significant difference in the number of renal 
adverse events detected by computed tomography between the infrarenal fixation (10, 6.8%) 
group and the suprarenal fixation (3, 3.8%) group (P = 0.550). 
Proximal fixation devices artificially elevate the aortoiliac bifurcation, requiring contralateral 
limb cannulation some distance from the patient’s native aortoiliac bifurcation. In the case of 
a narrow distal aorta, bi-lobe or saccular aneurysms, such maneuvers can be challenging or 
unachievable. An example of this is highlighted in a recent report regarding a newer device, 
where the distal aortic diameter averaged 33mm in enrolled patients, more than 50% 
increased over that of patients enrolled in the PowerlinkR anatomical fixation trials. Even 
with this large distal aortic diameter, intraoperative limb stenosis requiring stenting 
occurred in 11% of patients, with intervention within 30 days for limb occlusion or 
thrombosis performed in 2.2% of patients, leading the authors to suggest prophylactic 
intraoperative limb stenting. It is not known if the long-term rate of limb kinking/occlusion 
will be similar to the 4.3% rate reported for other currently available devices. Interestingly, 
endografts with fully supported limbs (e.g., Excluder, PowerlinkR) appear to have greater 
resistance to intraoperative stenosis and kinking and the lowest reported rates of limb 
kinking or occlusion with long-term follow-up (1.7%, 1.2%). Because the PowerlinkR device 
includes a pre-cannulated contralateral limb requiring only 9Fr percutaneous access, 
anatomical fixation implantation eliminates the cannulation problem.  
In a multinational registry analysis of patients presenting with coronary artery disease, 
cerebrovascular disease, or peripheral arterial disease, patients with abdominal aortic 
aneurysms were found to have a three-fold increased incidence of peripheral artery disease 
than those without abdominal aortic aneurysms. One cannot deny that preserving the native 
aortoiliac bifurcation after endovascular aneurysm repair to enable future peripheral 
interventions is an important consideration. The anatomically fixed PowerlinkR device 
relining the abdominal aorta offers the opportunity for such subsequent peripheral 
interventions post-endovascular aneurysm repair. 
The complexity of abdominal aortic aneurysm is commonly characterized based on location 
and involvement of visceral vessels. Infrarenal aneurysms generally involve the infrarenal 
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aorta and may involve the aortoiliac vasculature. A subset of infrarenal aneurysms extend 
up to the level of but do not involve the renal arteries (juxtarenal aneurysms) or extend 
further to involve one or both of the renal arteries (pararenal aneurysms). As noted 
previously, a substantial proportion of infrarenal aneurysms are not suitable for 
endovascular aneurysm repair due to unfavorable proximal neck anatomy (e.g., severely 
angulated, dilated, short, or encroaching on or involving the renal arteries). In regulatory 
studies of infrarenal endovascular aneurysm repair, patients were carefully selected to 
ensure neck length and angulation requirements were met in order to optimize outcomes. 
Shorter length or greater angulation has been reported since the original trials to increase 
the risk of migration and Type Ia endoleak and associated with need for intervention. 
Owing to the increased risk of renal complications, mesenteric ischemia and other 
complications following open repair of juxtarenal or pararenal aneurysms compared to 
infrarenal aneurysms, researchers have sought to extend a totally endovascular technique to 
repair these aneurysms. In this treatment, it is essential to maintain the patency of the renal 
arteries and other visceral vessels. Up to now, only homemade or customized fenestrated 
stent-grafts with the use of commercially available uncovered or covered vascular stents 
have been used for the repair of juxtarenal aneurysms. The key limitation to this approach is 
the need to customize the design and manufacture of each stent-graft to a particular patient 
anatomy. This requires a lengthy period of time for planning, manufacture, and delivery of 
the device, and is very costly. As a result, physicians have begun to seek other options, such 
as hybrid debranching techniques or chimney techniques. However, these options remain 
suboptimal. The concept of an off the shelf alternative to customization has been postulated; 
however this has yet to be realized. More recently, an off-the-shelf fenestrated stent-graft 
system has been developed based on the PowerlinkR stent-graft. Integral to this system is the 
bifurcated stent-graft, anatomically fixed at the aortoiliac bifurcation, a fenestrated proximal 
extension with proprietary design, and compatible covered renal stents. All devices are 
constructed from cobalt chromium alloy for exceptional durability, and have a high density 
ePTFE covering. Initial estimates suggest this system will be applicable to 80% or more of 
patients with juxtarenal or pararenal aneurysm, without need for customization. Initial 
clinical experience will be available by the end of this year. Multicenter clinical trials are 
expected to commence in 2011, and if successful, would significantly increase the numbers 
of patients who could be treated endovascularly, would significantly reduce the time from 
diagnosis to treatment, and would represent significant improvement in cost effectiveness 
over the currently available options. 
The field of endovascular aneurysm repair for abdominal aortic aneurysm has matured in 
recent years and is progressing into ever more challenging anatomy than treated in early 
trials. The problems of distal migration or endoleak remain, particularly in the more 
challenging anatomies. Clearly utilization of the native aortoiliac bifurcation as a strong 
foundation on which to place the PowerlinkR bifurcated stent-graft followed by achievement 
of proximal seal with an aortic extension if needed is a simple yet elegant way of mitigating 
the risk of migration and endograft destabilization. The emergence of anatomical fixation 
with the availability of a well designed off the shelf proximal extension and visceral branch 
grafts, starting clinical evaluation at this time, has strong potential to not only address a 
significant unmet clinical need, but to address global demands for cost-effective options for 
these patients. Furthermore, the prospective clinical validation of a totally percutaneous 
approach to endovascular aneurysm repair will serve to advance this technique and its use 
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in properly selected patients. Other proximal fixation devices are in development or 
available in some regions that feature lower profile delivery systems and enhanced proximal 
fixation attachment mechanisms. A novel sac anchoring endovascular prosthesis (the Nellix 
device) is in final stages of regulatory review in Europe. This technology obliterates the 
aneurysm sac with a polymer-filled endobag and paving endoframe lumens. Although it 
has the potential to significantly reduce or eliminate the incidence of any endoleak, and thus 
reduce the surveillance necessary with other endovascular prostheses. Broader and longer 
term study will be necessary to validate this fully.  
The next horizon yet to be addressed is the thoracic aorta, particularly the ascending aorta, 
where no adequate endovascular options yet exist. Although in final proprietary 
development at this time, a novel endografting approach utilizing a thoracic anatomical 
fixation technique with in situ fenestration and branch preservation is on the future horizon. 
5. Conclusions 
Our experience demonstrated that building up the endovascular exclusion system in the 
abdominal aortic aneurysms using the unibody PowerlinkR device with proximal cuff 
and/or additional PalmazR stent showed a satisfactory long-term outcome, even proved safe 
and effective in treating abdominal aortic aneurysms with short and/or angulated neck. 
With this intuitive approach, stent graft migration and its related potential complications are 
virtually eliminated. However, prospective longer follow-up in multicenter randomized 
controlled larger series are necessary to confirm these encouraging outcomes. 
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